Sponsored by
2026 finalists are announced
We are thrilled to announce the Finalists for the 2026 disruptive technology award! Join us on Monday, July 27, at the special session in Anaheim to find out who will win this year's award.
- Anvil Diagnostics, Inc. | MycoScan
- Augurex Life Sciences Corp. | SPINEstat® Immunoassay
- Kompass Diagnostics | Multimodal Electrical Sensor
Learn about them and their disruptive technologies.
DTAC Special Session
Anaheim Convention Center | Room Ballroom ABC
Monday, July 27, 2026 from 4:30 PM - 6:00 PM
In this special session, three finalists will deliver presentations that explain their leading-edge technology and showcase supporting evidence for the performance and impact of their novel development. Each presentation will be followed by a brief Q&A with an expert panel of judges who will rank disruptiveness, innovation, and impact among other factors. The winner will be announced at the close of the event.
Mission statement
ADLM's Disruptive Technology Award Competition (DTAC) aims to evaluate and elevate companies developing new diagnostic tools and technologies that have the potential to improve patient care. DTAC grants the diagnostic and laboratory medicine community an early look at innovative and impactful products that address current gaps in the field and/or improve upon existing solutions.
Learn more about the competition and view past winners.
Questions?
Email [email protected] with any questions about the competition.